Levi, JE; Nascimento, MC; Sumita, LM; de Souza, V; Freire, WS; Mayaud, P; Pannuti, CS; (2011) Non-Detection of Human Herpesvirus 8 (HHV-8) DNA in HHV-8-Seropositive Blood Donors from Three Brazilian Regions. PloS one, 6 (8). ISSN 1932-6203 https://researchonline.lshtm.ac.uk/id/eprint/132

Kitchener, HC; Almonte, M; Thomson, C; Wheeler, P; Sargent, A; Stoykova, B; Gilham, C; Baysson, H; Roberts, C; Dowie, R; +6 more... Desai, M; Mather, J; Bailey, A; Turner, A; Moss, S; Peto, J; (2009) HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. The lancet oncology, 10 (7). pp. 672-682. ISSN 1470-2045 DOI: https://doi.org/10.1016/S1470-2045(09)70156-1 Full text not available from this repository.

Appleby, P; Beral, V; de Gonzalez, AB; Colin, D; Franceschi, S; Goodhill, A; Green, J; Peto, J; Plummer, M; Sweetland, S; (2007) Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet, 370 (9599). pp. 1609-1621. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(07)61684-5 Full text not available from this repository.

Legood, R; Gray, A; Wolstenholme, J; Moss, S; (2006) Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ (Clinical research ed), 332 (7533). pp. 79-85. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.38698.458866.7C

Moss, S; Gray, A; Legood, R; Vessey, M; Patnick, J; Kitchener, H; (2006) Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ, 332 (7533). pp. 83-85. ISSN 1468-5833 DOI: https://doi.org/10.1136/bmj.38701.440961.7C

Legood, R; Gray, AM; Mahe, C; Wolstenholme, J; Jayant, K; Nene, BM; Shastri, SS; Malvi, SG; Muwonge, R; Budukh, AM; +1 more... Sankaranarayanan, R; (2005) Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. International journal of cancer Journal international du cancer, 117 (6). pp. 981-987. ISSN 0020-7136 DOI: https://doi.org/10.1002/ijc.21220 Full text not available from this repository.

Evans, HS; Newnham, A; Hodgson, SV; Møller, H; (2003) Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecologic oncology, 90 (1). pp. 131-136. ISSN 0090-8258 DOI: https://doi.org/10.1016/s0090-8258(03)00231-2 Full text not available from this repository.

Mayaud, P; Gill, DK; Weiss, HA; Uledi, E; Kopwe, L; Todd, J; Ka-Gina, G; Grosskurth, H; Hayes, RJ; Mabey, DC; +1 more... Lacey, CJ; (2001) The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sexually transmitted infections, 77 (4). pp. 248-54. ISSN 1368-4973 https://researchonline.lshtm.ac.uk/id/eprint/16329 Full text not available from this repository.